Journals / Türkderm Türk deri hastalıkları ve frengi arşivi / 2020 / Cilt: 54 - Sayı: 1

Giant variant of acquired perforating dermatosis in a patient with diabetes mellitus

Diabetes mellituslu bir olguda edinsel perforan dermatozun dev varyantı

Pages
25–28
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Based on its rare occasions, we submit a giant variant of acquired perforating dermatosis with a collagen fiber predominant elimination pattern, which is treated with nbUVB.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Perforating dermatoses are a group of diseases characterized by transepidermal elimination of dermal components such as collagen, elastin and fibrin.
📊
Key Findings & Data:Perforating dermatoses primarily include four main forms: Reactive perforating collagenosis, elastosis perforans serpiginosa, perforating folliculitis and acquired perforating dermatosis.
💡
Conclusion & Impact:Based on its rare occasions, we submit a giant variant of acquired perforating dermatosis with a collagen fiber predominant elimination pattern, which is treated with nbUVB.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Perforating dermatoses are a group of diseases characterized by transepidermal elimination of dermal components such as collagen, elastin and fibrin. Perforating dermatoses primarily include four main forms: Reactive perforating collagenosis, elastosis perforans serpiginosa, perforating folliculitis and acquired perforating dermatosis. There is limited data about perforating dermatoses in the literature. Because of their rare appearance, they can be easily misdiagnosed. Acquired perforating dermatosis is a systemic disease such as diabetes and chronic renal failure; and it should be considered in case of pruritic papulonodules and giant plaques with central crater in a patient. In addition to the treatment of underlying disease in the first stage; narrow band ultraviolet B (nbUVB) is evaluated to be effective in these cases. Based on its rare occasions, we submit a giant variant of acquired perforating dermatosis with a collagen fiber predominant elimination pattern, which is treated with nbUVB.

Özet

Perforan dermatozlar, kollajen, elastin, fibrin gibi dermal bileşenlerin transepidermal eliminasyonu ile karakterize bir grup hastalıktır. Perforandermatozlar primer olarak reaktif perforan kollajenöz, elastozis perforans serpiginoza, perforan folikülit ve edinsel perforan dermatoz olmaküzere dört ana hastalık formunu kapsar. Perforan dermatozlarla ilgili literatürde az sayıda bilgi mevcuttur. Nadir görülmelerinden ötürü kolaylıkladikkatten kaçabilmektedirler. Edinsel perforan dermatoz, özellikle diyabet, kronik böbrek yetmezliği gibi sistemik bir hastalığı olup kaşıntılıpapülonodülleri, merkezi kraterli dev plakları olan hastalarda akla gelmelidir. Bu hastalarda öncelikli olarak alta yatan hastalığın tedavisine ekolarak dar bant Ultraviyole B’nin (dbUVB) etkili olabildiğini düşünmekteyiz. Biz de oldukça nadir görülmesi nedeniyle, dbUVB ile tedavi ettiğimiz,kollajen lif eliminasyon paterninin hakim olduğu dev lezyonlu bir edinsel perforan dermatoz olgusunu sunduk.

🔖

Cite This Article

KILIÇ, A., ÖZÇELİK, S., LEBE, B., DOĞAN, Y. (2022). Giant variant of acquired perforating dermatosis in a patient with diabetes mellitus. Türkderm Türk deri hastalıkları ve frengi arşivi, Cilt: 54 - Sayı: 1, 25–28. https://ajindex.com/articles/622489

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Farrell AM: Acquired perforating dermatosis in renal and diabetic patients. Lancet 1997;349:895-6.
  2. Garcia-Malinis AJ, Del Valle Sanchez E, Sanchez-Salas MP, Del Prado E, Coscojuela C, Gilaberte Y: Acquired perforating dermatosis: clinicopathological study of 31 cases, emphasizing pathogenesis and treatment. J Eur Acad Dermatol Venereol 2017;31:1757-63.
  3. Metterle L, Magro CM, Zang JB: Giant variant of acquired perforating dermatosis in a renal dialysis patient. JAAD Case Rep 2017;3:42-4.
  4. Zelger B, Hintner H, Auböck J, Fritsch PO: Acquired perforating dermatosis. Transepidermal elimination of DNA material and possible role of leukocytes in pathogenesis. Arch Dermatol 1991;127:695-700.
  5. Alyahya GA, Heegaard S, Prause JU: Ocular changes in a case of Kyrle’s disease. 20-year follow-up. Acta Ophthalmol Scand 2000;78:585-9.
  6. Saray Y, Seçkin D, Bilezikçi B: Acquired perforating dermatosis: Clinicopathological features in twenty-two cases. J Eur Acad Dermatol Venereol 2006;20:679-88.
  7. Hoque SR, Ameen M, Holden CA: Acquired reactive perforating collagenosis: Four patients with a giant variant treated with allopurinol. Br J Dermatol 2006;154:759-62.
  8. Ohe S, Danno K, Sasaki H, Isei T, Okamoto H, Horio T: Treatment of acquired perforating dermatosis with narrowband ultraviolet B. J Am Acad Dermatol 2004;50:892-4.
  9. Gnanaraj P, Venugopal V, Sangitha C, Rajagopalan V, Pandurangan CN: A giant variant of acquired reactive perforating collagenosis associated with hydronephrosis: successful treatment with allopurinol. Int J Dermatol 2009;48:204-6.
  10. Razmi TM, Chatterjee D, Parsad D: Giant variant of acquired reactive perforating collagenosis in diabetic nephropathy. Postgrad Med J 2019;95:52-3.
  11. Kim SW, Kim MS, Lee JH, et al: A clinicopathologic study of thirty cases of acquired perforating dermatosis in Korea. Ann Dermatol 2014;26:162-71.
  12. Lee YS, Vijayasingam S, Tan YO, Wong ST: Acquired perforating dermatosis associated with recurrent hepatocellular carcinoma. Int J Dermatol 1996;35:743-5.
  13. Pedragosa R, Knobel HJ, Huguet P, Oristrell J, Valdes M, Bosch JA: Reactive perforating collagenosis in Hodgkin's disease. Am J Dermatopathol 1987;9:41-4.
  14. Ruiz Villaverde R, Martin Sanchez MC, Blasco Melguizo J, Naranjo Sintes R: [Reactive perforating collagenosis and colon carcinoma]. Rev Clin Esp 2002;202:298-9.
  15. Karpouzis A, Tsatalas C, Sivridis E, et al: Acquired reactive perforating collagenosis associated with myelodysplastic syndrome evolving to acute myelogenous leukaemia. Australas J Derma